ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
2 1. NAME OF THE MEDICINAL PRODUCT ADCIRCA 20 mg film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each film-coated tablet contains 20 …
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Product, Management, Lifecycle, Product lifecycle management
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guidelines, Good, Practices, Clinical, Good clinical practice e6
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
Guidelines, Good, Practices, Guideline on good pharmacovigilance practices, Pharmacovigilance
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
Guidelines, European, Agency, Medicine, Harmonised, European medicines agency, Ich harmonised
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Product, Medicinal, Traditional, Herbal, Products1 traditional herbal medicinal products, Products1
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Good, Practices, Pharmaceutical, Manufacturing, Active, Ingredients, Good manufacturing practice for active, Good manufacturing practice for active pharmaceutical ingredients
Related documents
Malattia di La Peyronie.
www.urologia-andrologiagiovanni23.itMalattia di La Peyronie. Conosciuta anche con il termine di Induratio Penis Plastica (IPP), e scoperta per la prima volta nel 1743 da Francois de La Peyronie…
ACTAS ENFERMEDAD DE LA PEYRONIE Y OTRAS …
www.aeu.esENFERMEDAD DE LA PEYRONIE Y OTRAS ALTERACIONES MORFOMÉTRICAS DEL PENE Tema Monográfico LXVI Congreso Nacional de …
Abnormalities of the Plantar Soft Tissues - …
www.bonepit.comObjectives 1) Review normal plantar anatomy of the foot 2) Describe optimal technique for MR Imaging of the foot 3) Review the most common abnormalities affecting the
Soft, Plantar, Abnormalities of the plantar soft, Abnormalities
I-TECH PHYSIO
www.itechmedicaldivision.comIACER S.r.l. 3 di 44 MNPG154 Rev. 05 27/06/16 Summary Summary 3 Technical Specifications 4
PRODUCT INFORMATION - Medicines
www.medicines.org.auVersion: pfpcaviv10516 Supersedes: pfpcaviv11215 Page 1 of 10 PRODUCT INFORMATION CAVERJECT IMPULSE (alprostadil) NAME OF THE MEDICINE Non-proprietary name: Alprostadil, Prostaglandin E
Public Assessment Report Decentralised Procedure - …
www.mhra.gov.ukPAR Sildenafil 25 mg, 50 mg and 100 mg film-coated tablets PL 34771/0143-5; UK/H/4673/001-3/DC 1 Public Assessment Report Decentralised Procedure
Successful Self Penile Injection Hints, Questions …
www.ustoo.org1 Successful Self Penile Injection Hints, Questions and Answers Greetings! This document was prepared to make the process as easy and painless as possible for men
Successful, Thin, Self, Injection, Successful self penile injection hints, Penile